Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for people living with kidney disease. Please review our social media guidelines at: https://akebia.com/social-media-guidelines/
Looking for a particular Akebia Therapeutics employee's phone or email?
The Akebia Therapeutics annual revenue was $169.9 million in 2026.
John Butler is the President and CEO of Akebia Therapeutics.
267 people are employed at Akebia Therapeutics.
Akebia Therapeutics is based in Cambridge, Massachusetts.
The NAICS codes for Akebia Therapeutics are [5417, 541, 54, 541714, 3254, 32, 325, 54171].
The SIC codes for Akebia Therapeutics are [873, 283, 28, 87].